scPharmaceuticals Inc
SCPH
Market Cap$293.14M
Close$
$8.88
59.4% upside
Current Fair Value
59.4% upsideUndervalued by 59.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $293.14 Million |
|---|---|
| Enterprise Value | $305.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.91 |
| Beta | 0.39 |
| Outstanding Shares | 53,719,662 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.22 |
|---|---|
| PEG | -58.94 |
| Price to Sales | - |
| Price to Book Ratio | -5.57 |
| Enterprise Value to Revenue | 6.12 |
| Enterprise Value to EBIT | -4.53 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -2.51 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About scPharmaceuticals Inc
CEO: John Tucker